Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Functionalisation of ultra-bright all organic nanoparticles for super resolution imaging in intact brain preparations

Project description

Nanoparticles may soon be shedding light on disease processes

Nanoparticles, materials that are less than 100 nanometres in at least one dimension, are not new. Nature has created all types of nanoparticles found in volcanic ash, soot, ocean spray and sand. Sterling silver forks even release small quantities of silver nanoparticles into the environment. Harnessing the potential of engineered nanoparticles for biomedical applications in human cells relies on meeting some very stringent requirements including stability, non-toxicity, and functionalisation. The EU-funded NanoFUNC project is focusing attention on all-organic light-emitting nanoparticles for biomedical imaging. To make sure they light up targets of interest, scientists are functionalising the most promising nanoparticles to track neurotransmitter receptors in living brain slices. Success should lead to patentable nanoparticles for a variety of bioimaging applications.

Objective

Nanotechnologies have the potential to revolutionise our understanding of devastating diseases such as cancer or neuropathologies. By combining light-emitting nanoparticles (NPs) and super-resolution imaging, it is possible to observe living tissues at the molecular scale, resulting in images of unprecedented detail. To this aim, the ideal NP should be bright, stable, small, spectrally relevant, versatile, targetable, and non-toxic. These features have been sought after by chemists, physicists and biologists alike for more than a decade but their presence in a single NP has not been achieved to date. The objective of the NanoFUNC project is thus to develop the next generation of NPs displaying all the above properties.
We propose to achieve this by conferring targeting properties to the latest all organic NPs of the host laboratory already displaying promising spectral characteristics. We will first validate the functionalisation of these new tools on model cellular systems before applying them to track neurotransmitter receptors deep in intact brain slices of healthy and schizophrenia rat models. We expect this project to impact all communities benefiting from advances in bioimaging including neuroscience, medicine and cell biology as a whole. We thus envisage to patent the obtained NPs for use in marketable bioimaging applications.
The transfer of knowledge between the expertise of the host in nanochemistry and that of the experienced researcher in neurobiology provides a unique opportunity to successfully complete this highly interdisciplinary project. Moreover, the mobility of the researcher back to France in an internationally renowned laboratory is sure to enhance her career prospects as she aims to become an independent researcher in the near future. Together, the host and the researcher will strive for excellent scientific results and build a career plan involving training, management and communication to bring the researcher to full professional maturity.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF-EF-RI - RI – Reintegration panel

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2018

See all projects funded under this call

Coordinator

UNIVERSITE DE BORDEAUX
Net EU contribution
€ 196 707,84
Address
PLACE PEY BERLAND 35
33000 Bordeaux
France
Region
Nouvelle-Aquitaine Aquitaine Gironde
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 196 707,84